Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety Alongside other industry leaders, Definitive Healthcare demonstrates commitment to the highest standard of health data safety

GlobeNewsWire • Oct 1, 2026

Definitive Healthcare Appoints Clay Ritchey as CEO

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that its Board of Directors has appointed Clay Ritchey as the Company's next Chief Executive Officer and as a member of the Board of Directors, each effective September 8, 2026.

GlobeNewsWire • Sep 2, 2026

Special Committee of Definitive Healthcare Board Confirms Receipt of Going-Private Proposal from Advent International

FRAMINGHAM, Mass., Sept. 02, 2026 (GLOBE NEWSWIRE) -- The special committee (the “Special Committee”) of the Board of Directors of Definitive Healthcare Corp. (the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it has received a non-binding indication of interest (the “Proposal”), dated as of September 1, 2026, from Advent International, L.P., on behalf of certain of its managed funds (collectively, “Advent”), to acquire all of the outstanding shares of the Company's Class A common stock (the “Class A Common Stock”) and all of the outstanding limited liability company interests of AIDH TopCo, LLC (the “Definitive OpCo Units”), in each case, that are not already owned by Advent or Jason Krantz, the Company's founder and Executive Chairman, for an all-cash purchase price of $1.02 per share of Class A common stock, and an equivalent amount per Definitive OpCo Unit.

GlobeNewsWire • Sep 2, 2026

Definitive Healthcare Q2 Earnings Call Highlights

Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and continued investments in artificial intelligence products as key components of its plan to return to growth.

MarketBeat • Aug 10, 2026

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 11, 2026

Definitive Healthcare Corp. (DH) Q2 Earnings Surpass Estimates

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.

Zacks Investment Research • Aug 10, 2026

Definitive Healthcare Launches Early Adopter Program for New AI-Powered Healthcare Intelligence Platform

Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions

GlobeNewsWire • Aug 6, 2026

Definitive Healthcare Announces Timing of Its Second Quarter 2026 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare market data and analytics, today announced that it will report financial results for its second quarter ended June 30, 2026, on Monday, August 10, 2026 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company's financial results.

GlobeNewsWire • Aug 3, 2026

Analysts Estimate Definitive Healthcare Corp. (DH) to Report a Decline in Earnings: What to Look Out for

Definitive Healthcare (DH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Jul 30, 2026

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

FRAMINGHAM, Mass., July 27, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of one senior leader, the Human Capital Management and Compensation Committee (the “Committee”) of Definitive Healthcare's Board of Directors granted inducement awards. The Committee granted Srinivas Attipalli of the Company, Definitive Healthcare's new SVP and Head of AI & Data - Product, an inducement award consisting of 1,063,830 time-based restricted stock units (“RSUs”), effective July 24, 2026. These awards were individually negotiated and granted as an inducement material to Mr. Attipalli's respective commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4).

GlobeNewsWire • Jul 27, 2026